Growth hormone axis
IGF-1 DES
Also called DES(1-3)IGF-1
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
IGF-1 DES at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 20–50 mcg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Time to steady level
- ~2 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for IGF-1 DES describe 20–50 mcg per administration. Descriptive only, not a recommendation.
A truncated IGF-1 cleared quickly; human pharmacokinetics are not established.
A truncated, locally potent IGF-1 studied in cell and animal models; no human study fixes an injected amount or schedule, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- DES(1-3)IGF-1 laboratory literatureA truncated IGF-1 studied in cell and animal models; human injected amounts are community-derived.